Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001
Globe Newswire•05/08/2026•06:50 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.